Adma Biologics reported $135.86M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Takeda JPY 876.35B 118.43B Mar/2026